SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liverJay D. Horton, Michael S. Brown|Journal of Clinical Investigation|2002Cited by 4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Børge G. Nordestgaard et al.|European Heart Journal|2017Cited by 3.8k
Molecular mediators of hepatic steatosis and liver injuryJeffrey D. Browning, Jay D. Horton|Journal of Clinical Investigation|2004Cited by 1.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, M. John Chapman et al.|European Heart Journal|2020Cited by 1.5k
Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.Jay D. Horton, Hitoshi Shimano|Journal of Clinical Investigation|1998Cited by 707